Surveillance After a Previous Cutaneous Melanoma Diagnosis: A Scoping Review of Melanoma Follow-Up Guidelines

por Johnston, Leah, Starkey, Samantha, Mukovozov, Ilya, Robertson, Lynne, Petrella, Teresa, Alhusayen, Raed
Publicado 2023

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements

por Thawer, Alia, Miller, Wilson H., Gregorio, Nancy, Claveau, Joël, Rajagopal, Sudha, Savage, Kerry J., Song, Xinni, Petrella, Teresa M.
Publicado 2021

The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT

por Soliman, Magdy, Petrella, Teresa, Tyrrell, Pascal, Wright, Frances, Look Hong, Nicole J., Lu, Hua, Zezos, Petros, Jimenez-Juan, Laura, Oikonomou, Anastasia
Publicado 2019

Restructuring Skin Cancer Care in Ontario: A Provincial Plan

por Milkovich, John, Hanna, Tim, Nessim, Carolyn, Petrella, Teresa M., Weatherhead, Louis, Chan, An-Wen, Irish, Jonathan C., Murray, Christian, Bannerman, Grace, Holloway, Claire, Forster, Katharina, Pazzano, Laura, Wright, Frances C.
Publicado 2021

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

por Dai, Wei Fang, Beca, Jaclyn M., Croxford, Ruth, Isaranawatchai, Wanrudee, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Hanna, Timothy P., Chan, Kelvin K.W.
Publicado 2020

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization

por Lu, Brandon, Dai, Wei Fang, Croxford, Ruth, Isaranuwatchai, Wanrudee, Beca, Jaclyn, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Mercer, Rebecca E., Hanna, Timothy P., Chan, Kelvin K. W.
Publicado 2023

Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients

por Zhou, Sarah, Sikorski, Daniel, Xu, Honghao, Zubarev, Andrei, Chergui, May, Lagacé, François, Miller, Wilson H., Redpath, Margaret, Ghazal, Stephanie, Butler, Marcus O., Petrella, Teresa M., Claveau, Joël, Nessim, Carolyn, Salopek, Thomas G., Gniadecki, Robert, Litvinov, Ivan V.
Publicado 2021

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

por Tarhini, Ahmad A, Kang, Ni, Lee, Sandra J, Hodi, F Stephen, Cohen, Gary I, Hamid, Omid, Hutchins, Laura F, Sosman, Jeffrey A, Kluger, Harriet M, Eroglu, Zeynep, Koon, Henry B, Lawrence, Donald P, Kendra, Kari L, Minor, David R, Lee, Carrie B, Albertini, Mark R, Flaherty, Lawrence E, Petrella, Teresa M, Streicher, Howard, Sondak, Vernon K, Kirkwood, John M
Publicado 2021